Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel cancer vaccine combined with cyclophosphamide shows potential in a phase I trial

April 23, 2014

Novel PI3K-p110beta/delta inhibitor demonstrates potent antitumor efficacy in vivo

April 23, 2014

CRLX-522 leads to reduction of tumor growth in vivo

April 23, 2014

Safety, immunogenicity and efficacy of DCVAC/PCa vaccine in recurrent prostate cancer

April 23, 2014

Adamed presents a novel bioconjugate for tumor-targeted drug delivery

April 22, 2014

Cyclophilin inhibitor NVP-018 inhibits HBV preclinically

April 22, 2014

Researchers present further clinical data for Liproca depot

April 22, 2014

Novel miRNA biomarkers for predicting response to cardiac procedures

April 22, 2014

Genetic loci associated with ovarian cancer prognosis

April 22, 2014

FGFR inhibitor active against cells harboring genetic mutations

April 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...